Blane Walter - 02 Jul 2025 Form 4 Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Role: Director
Signature: /s/ Stephanie Swan, by Power of Attorney
Issuer symbol: HSDT
Transactions as of: 02 Jul 2025
Net transactions value: $0
Form type: 4
Filing time: 03 Jul 2025, 20:00:24 UTC
Previous filing: 08 Jan 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Walter Blane	Director	C/O HELIUS MEDICAL TECHNOLOGIES, INC., 642 NEWTOWN YARDLEY ROAD, SUITE 100, NEWTOWN	/s/ Stephanie Swan, by Power of Attorney	03 Jul 2025	0001340555

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HSDT	Stock Option (Right to Buy)	Award	$0	+2,600		$0.000000	2,600	02 Jul 2025	Class A Common Stock	2,600	$9.76	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 50% of the options vested immediately upon grant, and the remaining options vest in a series of four (4) successive equal quarterly installments on the last day of each quarter starting on September 30, 2025, subject to the Reporting Person's continued service through each applicable vesting period.